Reviewing Viveve Medical (NASDAQ:VIVE) and Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) and Viveve Medical (NASDAQ:VIVE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Semler Scientific and Viveve Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Semler Scientific	27.00%	20.31%	18.78%
Viveve Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Semler Scientific and Viveve Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0	0	0	1	4.00
Viveve Medical	0	0	0	0	0.00

Valuation & Earnings

This table compares Semler Scientific and Viveve Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semler Scientific	$68.18 million	4.25	$20.58 million	$2.05	19.43
Viveve Medical	$6.43 million	N/A	-$22.03 million	N/A	N/A

Semler Scientific has higher revenue and earnings than Viveve Medical.

Insider & Institutional Ownership

49.4% of Semler Scientific shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 5.7% of Viveve Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Semler Scientific has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

Summary

Semler Scientific beats Viveve Medical on 10 of the 10 factors compared between the two stocks.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

About Viveve Medical

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.